Product Information

CLIND PH-BENZOYL PEROX 1.2-5% is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $0.4086 per GM under NDC 45802073684. Its NADAC has been published 678 times since Nov 28, 2013.

FDA first approved this application on Jun 26, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CLIND PH-BENZOYL PEROX 1.2-5%

Clindamycin, Benzoyl Peroxide
$0.4086per GM

Strength

50; 10 mg/g; mg/g

NDC

45802073684

Classification

Generic

Dosage Form

GEL

Route

TOPICAL

Effective Date

11/18/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA090979

FDA Approved

6/26/2012

TE Code

AB

On Market Since

6/26/2012

Pharmacological Classes

Decreased Sebaceous Gland Activity
Lincosamide Antibacterial
Lincosamides
Neuromuscular Blockade

Price Statistics

The NADAC for CLIND PH-BENZOYL PEROX 1.2-5% has been published 678 times since Nov 28, 2013, and over the history we have for it it has declined 85.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.4086 per GM
All-time high$3.4311 (Apr 13, 2016)
All-time low$0.3909 (Jul 22, 2026)
52-week high$0.5354
52-week low$0.3909
Median price$1.0502
Average price$1.5400
Largest weekly change+44.6% (Aug 21, 2024)
Weeks tracked678
Tracking sinceNov 28, 2013

Price History

1W

-1.9%

1M

-1.9%

3M

+2.3%

6M

+0.2%

1Y

-23.7%

3Y

-19.0%

5Y

-37.7%

All

-85.9%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Clindamycin, Benzoyl Peroxide market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of CLIND PH-BENZOYL PEROX 1.2-5%?

The current National Average Drug Acquisition Cost (NADAC) for CLIND PH-BENZOYL PEROX 1.2-5%, manufactured by Padagis Israel Pharmaceuticals Ltd, is $0.4086 per GM (NDC 45802073684), effective Nov 18, 2026.

How has the price of CLIND PH-BENZOYL PEROX 1.2-5% changed over time?

Over the history we have for it, the NADAC for CLIND PH-BENZOYL PEROX 1.2-5% has declined 85.9%. It has been tracked across 678 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for CLIND PH-BENZOYL PEROX 1.2-5%?

Since Nov 28, 2013, the NADAC for CLIND PH-BENZOYL PEROX 1.2-5% has ranged from a low of $0.3909 (Jul 22, 2026) to a high of $3.4311 (Apr 13, 2016), with a median of $1.0502 per GM.

Are there cheaper alternatives to CLIND PH-BENZOYL PEROX 1.2-5%?

No other NADAC-published product currently shares the active ingredient and strength of CLIND PH-BENZOYL PEROX 1.2-5% in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures CLIND PH-BENZOYL PEROX 1.2-5%?

CLIND PH-BENZOYL PEROX 1.2-5% (NDC 45802073684) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.